Hospital
RSSArticles
-
From the Public Perspective
The COVID-19 pandemic is not over yet, but there may be light at the end of the tunnel, and what comes next is slowly coming into focus.
-
A Ground-Level Look at the COVID-19 Vaccine Rollout
About a month into the COVID-19 vaccine rollout, one surgery center nurse leader still was struggling to secure shots for her staff. The hurdles included multiple phone calls, dead-end leads, and long waits for an unsure outcome.
-
OR Teams Often Exposed to Toxic Chemicals in Surgical Smoke
Executive nurse leaders can collaborate with states and professional organizations to advocate for smoke evacuation legislation, and they can create policies at their facilities to mitigate surgical smoke.
-
Try Bolstering Patient Care Through Shared Decision-Making
When surgeons begin shared decision-making with patients, it can be an eye-opening experience that improves patient-surgeon trust and communication.
-
Revising Policies Should Be a Priority, Even as COVID-19 Pandemic Continues
Creating new policies or revising existing procedures should be a priority to meet the challenges of managing the ongoing COVID-19 pandemic and administering the vaccine. Follow these six steps to make the process easier.
-
A Guide to Improving Surgery Center Billing Practices
Surgery centers could improve their financial bottom line by focusing on following best practices in revenue cycle management.
-
Biden Administration Takes First Steps Against COVID-19
The new president signed a series of executive actions to accelerate nation’s pandemic response.
-
FWA Revisited: ‘Checking the Box’ and IO Responsibilities Under the Revised Common Rule
Revisions to the Common Rule took effect in 2018, but questions remain about how these changes have affected the Federalwide Assurance (FWA) and institutional responsibilities under the FWA.
-
Chief Ethical Considerations for Continued COVID-19 Vaccine Research
The COVID-19 pandemic has created more uncertainty in human research protections in 2021. One issue IRBs will face is whether the benefits continue to outweigh the risks for people who enroll in COVID-19 vaccine studies.
-
Research World Can Help Build Trust Among Minorities
The COVID-19 vaccine rollout has raised issues about trust among many Americans who are hesitant or unwilling to take the vaccine. The issue of trust is especially problematic among minority communities that have been harmed in historic medical and research incidences. People also are skeptical of a vaccine that was developed in record time, considering most vaccines take 10-15 years to make it to market.